Home
Contact
Careers
Terms and Conditions
Privacy Policy
About Arcturus
RNA Medicines
Technologies
Pipeline
Business Development
Publications
Investor Relations

Arcturus Announces Self-amplifying COVID-19 mRNA Vaccine Candidate ARCT-154 Meets Primary Efficacy Endpoint in Phase 3 Study

April 20, 2022

Home
Contact
Careers
Terms and Conditions
Privacy Policy
© 2023 Arcturus Therapeutics, Inc.